Cision PR Newswire

MATRADE PARTNERS WITH HKTVMALL TO LAUNCH “DISCOVER MALAYSIA @ HKTVMALL” CAMPAIGN

Featuring Selected halal certified Foods and Wellness Products, with HK$50 Off Purchases of HK$350 or More Ahead of Peak Online Shopping Season HONG KONG, Nov. 11, 2026 /PRNewswire/ -- Malaysia External Trade Development Corporation (MATRADE), through its Hong Kong office, has partnered with HKTVmall to launch the "Discover...

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on...

Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves

SINGAPORE, March 2, 2026 /PRNewswire/ -- Toku Ltd. ("Toku", "投酷有限公司" or the "Company", and together with its subsidiaries, the "Group"), a Singapore-incorporated AI-powered customer...

Understanding China’s whole-process people’s democracy

BEIJING, March 2, 2026 /PRNewswire/ -- A report from People's Daily: The upcoming "two sessions," the annual meetings of China's top legislature, the National...

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

SAN FRANCISCO and SUZHOU, China, March 2, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and...